Funding · Company
Alessa Therapeutics, Inc.
San Carlos, CAHealthcare
Alessa Therapeutics, Inc. of San Carlos, CA has disclosed $25M across 1 Form D offering filed with the SEC on May 1, 2025.
$25M
Total disclosed
1
Form D offering
Offerings on file
Each amount is as reported on that filing, cumulative across its own amendments. Newest first.
$25M
Form D · May 1, 2025 ↗
Q2 2025
· target $32M
Filing details
HeadquartersSan Carlos, CAIndustryHealthcare (Other Health Care)SEC CIK0001771653Offerings on file1
Source: SEC Form D structured data. Amounts are self-reported by the issuer on a notice filing — not audited, and cumulative across amendments. The website link is resolved automatically and may be wrong — tell us if it is. Full methodology →